Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

55 University Avenue, Suite 1003, Toronto, Canada

Wearewhowethought Nov. 15 at 11:43 PM

$GNS $QNTM $MMTLP $TSLA $MSTR Ladies and gentleman get your tickets now for the famous naked shorting and spoofing algo from virtu and citadel who will be on full display all day monday. doing the same thing they are signed in the lawsuit for step right up sec to watch an algo

1 · Reply

Pink05 Nov. 15 at 6:25 PM

$GNS Has anyone seen a mainstream media report on Genius Group’s Federal Class Action Market Manipulation lawsuit filed against Citadel Securities LLC and Virtu Americas LLC?? @business,@Reuters, @YahooFinance, @WSJ, @nytimes, @washingtonpost, @nypost, @latimes, @chicagotribune @USATODAY @CBS, @NBCNews, @ABC, @FoxBusiness @CNBC WHY isn’t every media outlet reporting on the expensive avenues small public companies have to take to expose the alleged (and often blatant) manipulation in their stock?? WHY isn’t the mainstream media exposing brokers who are pulling the buy buttons from allegedly oversold stocks while regulators look the other way? Details in the link below and $GNS CEO @rogerhamilton is available for comment $QNTM CEO @zsaeed has also filed a $700 Million lawsuit as he tried to expose the alleged manipulation in his company’s stock. He is also available for comment ___________ May 2025 $QNTM Quantum BioPharma's Response to the Defendants' Motion to Dismiss $700 Million Federal Market Manipulation Lawsuit. http://x.com/kshaughnessy2/… ____________ http://globenewswire.com/news-release/2… @Hamnakedshorts @FlyEaglesFly529 @BAMinvestor

0 · Reply

Kimmoo Nov. 15 at 11:42 AM

$AMC $BYND $GME $GNS $QNTM

0 · Reply

Madmen1402 Nov. 15 at 9:34 AM

$GNS also remember that $QNTM dropped their lawsuit in October 2024 and hit their highs almost 6 months later in June! So be patient. Lots to come. Especially the ERL situation.

2 · Reply

sompscheikhumjadroke Nov. 15 at 6:34 AM

$AMC $BYND $GME $GNS $QNTM nobody will care about and nobody will intervene the court will get order to close that without Condemnation

0 · Reply

Altairus Nov. 15 at 2:14 AM

$GNS $GME $AMC $QNTM $BYND

0 · Reply

JP1016 Nov. 15 at 2:13 AM

$GNS let the revolution begin $GME $AMC $QNTM $BYND

0 · Reply

jcolespartan Nov. 14 at 10:40 PM

$QNTM https://ir.geniusgroup.net/news-events/press-releases/detail/214/genius-group-files-federal-securities-class-action-lawsuit

0 · Reply

MAC2023 Nov. 14 at 5:36 PM

$GNS with the lawsuit NR coming up I would imagine it will be good for all companies that have been taken down by #IllegalMM #Spoofing #BlackMarket $QNTM $BINI and many more IMO they will all rise to the occasion !!! HALTED

1 · Reply

22Shares Nov. 14 at 1:39 PM

$QNTM $GNS I've been down a few rabbit holes...Red is BEST!!

0 · Reply

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Oct 31, 2025, 7:51 PM EDT - 15 days ago

Quantum BioPharma Ltd. Provides Corporate Update

Oct 29, 2025, 9:00 PM EDT - 17 days ago

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 23, 2025, 8:15 AM EDT - 24 days ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 20, 2025, 8:30 AM EDT - 27 days ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 14, 2025, 8:15 AM EDT - 4 weeks ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 9, 2025, 6:00 PM EDT - 5 weeks ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 5:40 PM EDT - 5 weeks ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 8, 2025, 8:00 AM EDT - 5 weeks ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 7, 2025, 11:00 AM EDT - 5 weeks ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 3, 2025, 7:00 AM EDT - 6 weeks ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 2, 2025, 7:57 AM EDT - 6 weeks ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 1, 2025, 7:50 AM EDT - 6 weeks ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Sep 29, 2025, 7:40 AM EDT - 6 weeks ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 7 weeks ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 7 weeks ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 2 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 2 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 2 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 3 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 3 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 3 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 3 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 3 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 3 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 3 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 30, 2025, 4:00 PM EDT - 3 months ago

Quantum BioPharma Shares' Rollercoaster Day: What's Going On?

Jul 22, 2025, 7:00 AM EDT - 4 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 5 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 5 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 5 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 5 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 5 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 5 months ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 5 months ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 6 months ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 6 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 6 months ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 20, 2025, 7:30 AM EDT - 6 months ago

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

May 19, 2025, 7:30 AM EDT - 6 months ago

Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000

May 16, 2025, 7:30 AM EDT - 6 months ago

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

May 12, 2025, 8:00 AM EDT - 6 months ago

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

May 6, 2025, 8:25 PM EDT - 6 months ago

Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript

May 5, 2025, 7:08 AM EDT - 6 months ago

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Apr 24, 2025, 7:00 AM EDT - 7 months ago

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Apr 22, 2025, 7:00 AM EDT - 7 months ago

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Apr 18, 2025, 8:00 PM EDT - 7 months ago

Quantum BioPharma Corporate Update

Apr 14, 2025, 7:30 AM EDT - 7 months ago

Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

Apr 3, 2025, 7:00 AM EDT - 8 months ago

Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

Apr 1, 2025, 2:00 AM EDT - 8 months ago

Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

Wearewhowethought Nov. 15 at 11:43 PM

1 · Reply

Pink05 Nov. 15 at 6:25 PM

0 · Reply

Kimmoo Nov. 15 at 11:42 AM

$AMC $BYND $GME $GNS $QNTM

0 · Reply

Madmen1402 Nov. 15 at 9:34 AM

$GNS also remember that $QNTM dropped their lawsuit in October 2024 and hit their highs almost 6 months later in June! So be patient. Lots to come. Especially the ERL situation.

2 · Reply

sompscheikhumjadroke Nov. 15 at 6:34 AM

$AMC $BYND $GME $GNS $QNTM nobody will care about and nobody will intervene the court will get order to close that without Condemnation

0 · Reply

Altairus Nov. 15 at 2:14 AM

$GNS $GME $AMC $QNTM $BYND

0 · Reply

JP1016 Nov. 15 at 2:13 AM

$GNS let the revolution begin $GME $AMC $QNTM $BYND

0 · Reply

jcolespartan Nov. 14 at 10:40 PM

$QNTM https://ir.geniusgroup.net/news-events/press-releases/detail/214/genius-group-files-federal-securities-class-action-lawsuit

0 · Reply

MAC2023 Nov. 14 at 5:36 PM

1 · Reply

22Shares Nov. 14 at 1:39 PM

$QNTM $GNS I've been down a few rabbit holes...Red is BEST!!

0 · Reply

gloryb Nov. 14 at 1:01 PM

$QNTM how much can it go down today

0 · Reply

JMGlife Nov. 14 at 12:54 PM

$GNS $QNTM

0 · Reply

Buymeanother Nov. 14 at 12:52 PM

$QNTM $GNS gee I wonder why the GNS page is glitching this morning?

1 · Reply

RamenSoups Nov. 14 at 7:27 AM

$QNTM Kevin the moron Malone made his clients but this toilet paper at $25 ? Lol dummies throwing money down the toilet. Still stinks

0 · Reply

NoFearHere Nov. 14 at 5:29 AM

$QNTM RESIT= 8.77+9.08+11.35 +13.66+14.44

0 · Reply

NoFearHere Nov. 14 at 5:28 AM

$QNTM🤯 crazy fall SPRTS= 7.60+6,87+6.12+5.60

0 · Reply

gloryb Nov. 13 at 6:10 PM

$QNTM 🖕

0 · Reply

FickleFin Nov. 12 at 7:34 PM

$QNTM dead stock.

0 · Reply

CoolCatTrades Nov. 12 at 4:46 PM

Made huge profit on this guys call, +9k$ Gave @MomentumZeus a FOLLOW . insane trader lol. He called CMCT couple days ago and it just ran 100%+ Watching $QNTM $LKNCY $SOPA $QNRX <<

0 · Reply

EatingWithSpork Nov. 11 at 10:15 PM

$QNTM place holders for dividend from lawsuit if it pays out.

0 · Reply

EatingWithSpork Nov. 11 at 9:51 PM

$QNTM what are the F contracts that just showed up in my brokerage account?

0 · Reply

EatingWithSpork Nov. 11 at 9:36 PM

$QNTM everything Roger touches turns to crap. He has the reverse Midas touch!

0 · Reply

Market Cap	28.08M
Revenue (ttm)	0.00
Net Income (ttm)	-14.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	74,500
Avg Vol	105,282
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	17%
Beta	0.54
Analysts	Sell
Price Target	$35.50